Save your place

Sign in to WhoBought

Please try again later.

Aclaris Therapeutics, Inc. (ACRS) institutional ownership

Latest close $5.62 Jul 22, 2026
Market cap$264M 52-week range SectorHealthcare
Funds holding · Q1 2026
124
reported ACRS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
68 buyers · 56 sellers

Aclaris Therapeutics, Inc. (ACRS) price and institutional activity

Dates

Q1 2026

$0 bought by 68 investors
Deep Track Capital, LPRa Capital Management, L.P. +66 more
$0 sold by 56 investors
Vivo Capital, LLCD. E. Shaw & Co., Inc. +54 more
Bought Sold Totals per quarter; hover a bar for the names.

Aclaris Therapeutics, Inc. (ACRS) institutional activity · 124

Investor Type Est. change Change Δ Own Date
Deep Track Capital, LP · New
Change +9.3M Date Q1 2026
Deep Track Capital, LP New· Q1 2026 +9.3M Q1 2026
Ra Capital Management, L.P. · New
Change +6.8M Date Q1 2026
Ra Capital Management, L.P. New· Q1 2026 +6.8M Q1 2026
Frazier Life Sciences Management, L.P. · New
Change +4.9M Date Q1 2026
Frazier Life Sciences Management, L.P. New· Q1 2026 +4.9M Q1 2026
Balyasny Asset Management L.P. · New
Change +3.4M Date Q1 2026
Balyasny Asset Management L.P. New· Q1 2026 +3.4M Q1 2026
Vivo Capital, LLC · Reduced
Change −2.2M Date Q1 2026
Vivo Capital, LLC Reduced· Q1 2026 −2.2M Q1 2026
Kalehua Capital Management LLC · New
Change +1.8M Date Q1 2026
Kalehua Capital Management LLC New· Q1 2026 +1.8M Q1 2026
Braidwell LP · New
Change +1.7M Date Q1 2026
Braidwell LP New· Q1 2026 +1.7M Q1 2026
D. E. Shaw & Co., Inc. · Reduced
Change −1.2M Δ Own −57.0% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −1.2M −57.0% Q1 2026
Citadel Advisors LLC Added· Q1 2026 +1.0M +86.6% Q1 2026
Vanguard · Added
Change +1.0M Date Q1 2026
Vanguard Added· Q1 2026 +1.0M Q1 2026
Woodline Partners LP · Added
Change +744K Date Q1 2026
Woodline Partners LP Added· Q1 2026 +744K Q1 2026
Morgan Stanley · Reduced
Change −669K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −669K Q1 2026
Renaissance Technologies LLC Reduced· Q1 2026 −623K −55.3% Q1 2026
BlackRock · Added
Change +602K Date Q1 2026
BlackRock Added· Q1 2026 +602K Q1 2026
Acadian Asset Management LLC · Reduced
Change −583K Date Q1 2026
Acadian Asset Management LLC Reduced· Q1 2026 −583K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 124

Famous investor activity in Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics, Inc. (ACRS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Mehra Anand · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Mehra Anand Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Schiff Andrew N. · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Schiff Andrew N. Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Humphries William D. · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Humphries William D. Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Molineaux Christopher P. · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Molineaux Christopher P. Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Milano Vincent · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Milano Vincent Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Gowen Maxine · Director 2 operations 0
Owned 0 Trade date Jun 5, 2026 Filed date Jun 8, 2026
Gowen Maxine Director 2 operations 0 0 Jun 5, 2026 Jun 8, 2026
Mehra Anand · Director 2 operations 53K
Owned 11K Trade date Jun 4, 2026 Filed date Jun 8, 2026
Mehra Anand Director 2 operations 53K 11K Jun 4, 2026 Jun 8, 2026
Schiff Andrew N. · Director 2 operations 53K
Owned 11K Trade date Jun 4, 2026 Filed date Jun 8, 2026
Schiff Andrew N. Director 2 operations 53K 11K Jun 4, 2026 Jun 8, 2026
Humphries William D. · Director 2 operations 53K
Owned 11K Trade date Jun 4, 2026 Filed date Jun 8, 2026
Humphries William D. Director 2 operations 53K 11K Jun 4, 2026 Jun 8, 2026
Molineaux Christopher P. · Director 2 operations 53K
Owned 11K Trade date Jun 4, 2026 Filed date Jun 8, 2026
Molineaux Christopher P. Director 2 operations 53K 11K Jun 4, 2026 Jun 8, 2026
Milano Vincent · Director 2 operations 53K
Owned 11K Trade date Jun 4, 2026 Filed date Jun 8, 2026
Milano Vincent Director 2 operations 53K 11K Jun 4, 2026 Jun 8, 2026
Gowen Maxine · Director 2 operations 53K
Owned 11K Trade date Jun 4, 2026 Filed date Jun 8, 2026
Gowen Maxine Director 2 operations 53K 11K Jun 4, 2026 Jun 8, 2026
12 of 12

Aclaris Therapeutics, Inc. (ACRS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Bml Investment Partners, L.P. 13.9M
% of shares outstanding 9.9% Filing date Apr 27, 2026
Bml Investment Partners, L.P. 13.9M 9.9% Apr 27, 2026
Biosion, Inc. 11.3M
% of shares outstanding 9.5% Filing date Nov 25, 2024
Biosion, Inc. 11.3M 9.5% Nov 25, 2024
Bonita Biotech (hk) Ltd 11.3M
% of shares outstanding 9.4% Filing date Jan 9, 2026
Bonita Biotech (hk) Ltd 11.3M 9.4% Jan 9, 2026
Vivo Opportunity Fund Holdings, L.P. 8.0M
% of shares outstanding 7.4% Filing date Nov 21, 2024
Vivo Opportunity Fund Holdings, L.P. 8.0M 7.4% Nov 21, 2024
Rock Springs Capital Management LP
% of shares outstanding 6.3% Filing date Nov 22, 2024
Rock Springs Capital Management LP 6.3% Nov 22, 2024
Vanguard Group Inc 6.7M
% of shares outstanding 6.2% Filing date Jul 29, 2025
Vanguard Group Inc 6.7M 6.2% Jul 29, 2025
Adage Capital Management, L.P. 5.3M
% of shares outstanding 4.9% Filing date Nov 13, 2025
Adage Capital Management, L.P. 5.3M 4.9% Nov 13, 2025
Rock Springs Capital Management LP 5.0M
% of shares outstanding 4.7% Filing date May 15, 2025
Rock Springs Capital Management LP 5.0M 4.7% May 15, 2025
8 of 18

Aclaris Therapeutics, Inc. (ACRS) ownership FAQ

Who owns ACRS?

124 reporting institutions disclosed ACRS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.